Open AccessSingle agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET
Author(s) -
Alessandro Gozzetti,
Vania Rossi,
Alfonso Cerase,
Giulia Papini,
Marzia Defina,
Monica Bocchia
Publication year - 2012
Publication title -
mediterranean journal of hematology and infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 31
ISSN - 2035-3006
DOI - 10.4084/mjhid.2012.041
Subject(s) - lenalidomide , medicine , multiple myeloma , magnetic resonance imaging , nuclear medicine , pomalidomide , pet ct , oncology , radiology , positron emission tomography
A 71 year old female with multiple myeloma presented with back pain seven year after autologous stem cell transplant. Skeletal bone survey and magnetic resonance imaging did not show a relapse that was evidenced by CT/PET. Lenalidomide as single agent induced a complete disappearance of the lesions 6 months later and confirmed after one year at CT/PET.